Provided By GlobeNewswire
Last update: Sep 16, 2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was published with multiple studies highlighting the advantages of optical genome mapping (OGM) in chromoanagenesis research.
Read more at globenewswire.comNASDAQ:BNGO (12/16/2025, 8:01:25 PM)
1.57
+0.03 (+1.95%)
Find more stocks in the Stock Screener


